Priority platform

Peptide Lab Platform

A guided peptide discovery and prioritization workflow for validation partners, starting with GLP-1 secretion targets and extending into broader shortlist-driven peptide programs.

GLP-1
first public wedge for platform validation
Guided
partner demos and scoped discovery briefs
Signals
prioritization logic, not biological proof
Request partner demo Open whitepaper

The problem it solves

Many peptide programs create more candidates than they can test. That is not a discovery advantage if the shortlist logic is weak. The real bottleneck is deciding which peptides deserve scarce assay bandwidth, and why.

Peptide Lab Platform is designed to improve that bottleneck. It narrows candidate space through a structured, explainable scoring and filtering workflow, then hands off a validation-ready package to the partner.

What the platform is not

  • Not a claim of efficacy.
  • Not a substitute for wet-lab validation.
  • Not a generic self-serve SaaS dashboard.
Why GLP-1 first

A concrete wedge for a broader platform

GLP-1 makes the platform legible because the validation path is concrete, but the underlying workflow is broader than one target.

Commercially legible

Partners can immediately understand the problem, assay context, and why shortlist quality matters.

Experimentally scoped

The first validation loop can be defined without pretending the platform has already solved everything end to end.

Platform-expandable

Once the partner sees the workflow on one concrete problem, the broader peptide opportunity becomes more credible.

Workflow

How the platform works

1. Generate

Start from source proteins or peptide sets and define the biological question plus partner constraints.

2. Filter

Apply chemistry, safety, tractability, and basic plausibility filters before expensive modeling or assays.

3. Prioritize

Combine structure-aware and explainable signals into a shortlist with rationale rather than opaque scores.

4. Validate

Hand off controls, baselines, and next-branch logic so assay results can actually inform the next move.

What a partner receives

The output is meant to be operational. It should reduce wasted validation cycles rather than add another layer of abstract analysis.

Candidate shortlist
A narrowed set with inclusion logic.
Evidence map
Signals that mattered and remaining uncertainty.
Validation brief
Controls, baselines, and first-loop recommendations.
Partner handoff
Failure modes and next-branch planning.

Best-fit partners

  • Labs that can run GLP-1 secretion assays or adjacent validation assays.
  • Ingredient or nutrition teams exploring shortlist-driven peptide opportunities.
  • Teams that want explicit rationale and feedback loops, not black-box outputs.

Current engagement shape

  • Guided demo: fit call plus platform walkthrough against a concrete use case.
  • Discovery brief: scoped first pass around peptide generation, filtering, and shortlist framing.
  • Validation loop: partner-facing handoff tied to a practical assay plan.
Evidence

Public proof points

Peptide Lab whitepaper

Public technical overview of the current prioritization workflow and validation framing.

Open page

Whitepaper and patent update

Public press post tying the whitepaper release to the first patent filing around the framework.

Read update

Contact for partner fit

Use the contact page to describe your assay setup, platform interest, or candidate-prioritization question.

Open contact

If you can validate peptides, start here.

Send the assay context, target question, and what you already know. We will tell you quickly whether a guided Peptide Lab engagement makes sense.

Request partner demo